Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JXSB2400033	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	Supplementary Application	2024-03-28					view
CXSL2200434	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	New Drug Application	2022-09-02		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
CXSL2200435	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	New Drug Application	2022-09-02		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
JXSB2101017	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	Supplementary Application	2021-06-04					view
JXSB2200001	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	Supplementary Application	2022-01-05					view
JXSL2101040	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	Import Drug Application	2021-06-08					view
CXSL2400688	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	New Drug Application	2024-10-12		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
JXSB2101061	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	Supplementary Application	2021-09-15					view
CXSB2400028	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	Supplementary Application	2024-03-29		Baiji Shenzhou (Suzhou) Biotechnology Co Ltd			view
JXSL2000150	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	Import Drug Application	2020-09-10	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	In Review	2020-09-09	view
JXSL2000163	注射用ZW25	zanidatamab	Lyophilized	Biological Products(1)	Import Drug Application	2020-09-29	百济神州（北京）生物科技有限公司	BeiGene (Beijing) Co Ltd	In Review	2020-09-28	view